GSK plc's (LON:GSK) recent soft profit numbers didn't appear to worry shareholders, as the stock price showed strength. Our analysis suggests that investors may have noticed some promising signs ...

Teva Pharmaceutical Industries Ltd. ADR-1.51% $18.8B ...

McDonalds is bringing back two iconic favorites to celebrate the 50th anniversary of its Ronald McDonald House charity. The Shamrock Shake has returned to mark the occasion along with one of the ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

Rgenta's in-house pipeline is headed by RGT-61159, a drug designed to inhibit the production of the cancer-associated MYB protein, which is in phase 1 testing. Also this week, GSK bolstered its ...

CEO Dame Emma Walmsley highlighted that GSK achieved 8% sales growth in 2024, reaching over £31 billion, with specialty medicines driving performance. Core operating profit grew 13%, supporting a ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Officially, it’s called the Cowboy Lodge, but locals refer to it as the “Ronald McDonald House.” While there’s no relation to McDonald’s, the multi-million dollar mansion, sitting near ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other stocks. The stock market extended its winning streak on Wednesday, closing firmer as investors ...